Results 181 to 190 of about 6,678 (298)

Dual Quaternion-Based Forward and Inverse Kinematics for Two-Dimensional Gait Analysis. [PDF]

open access: yesJ Funct Morphol Kinesiol
Vergara-Hernandez R   +4 more
europepmc   +1 more source

Quaternion Space [PDF]

open access: yesTransactions of the American Mathematical Society, 1902
openaire   +1 more source

ALGEBRAIC PROPERTIES OF BI-PERIODIC DUAL FIBONACCI QUATERNIONS

open access: yes, 2019
The purpose of the paper is to construct a new representation of dual quaternions called bi-periodic dual Fibonacci quaternions. These quaternions are originated as a generalization of the known quaternions in literature such as dual Fibonacci ...
Ekmekci, N., Gok, I, Ates, F.
core  

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Computational workflows for natural and biomedical image processing based on hypercomplex algebras. [PDF]

open access: yesPatterns (N Y)
Valous NA   +14 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy